Cadence Bank NA’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $406K | Sell |
3,029
-13,072
| -81% | -$1.88M | 2.52% | 7 |
|
|
2022
Q2 | $2.47M | Buy |
16,101
+343
| +2% | +$52.4K | 0.8% | 37 |
|
|
2022
Q1 | $2.56M | Buy |
15,758
+467
| +3% | +$67.8K | 0.71% | 42 |
|
|
2021
Q4 | $2.07M | Buy |
15,291
+7
| +0% | +$827 | 0.56% | 51 |
|
|
2021
Q3 | $1.65M | Sell |
15,284
-113
| -0.7% | -$12.9K | 0.49% | 55 |
|
|
2021
Q2 | $1.74M | Sell |
15,397
-477
| -3% | -$53.7K | 0.52% | 53 |
|
|
2021
Q1 | $1.72M | Buy |
15,874
+1,208
| +8% | +$129K | 0.54% | 49 |
|
|
2020
Q4 | $1.57M | Buy |
14,666
+676
| +5% | +$65K | 0.55% | 50 |
|
|
2020
Q3 | $1.23M | Sell |
13,990
-94
| -0.7% | -$8.85K | 0.48% | 54 |
|
|
2020
Q2 | $1.38M | Buy |
14,084
+1,338
| +10% | +$118K | 0.58% | 48 |
|
|
2020
Q1 | $972K | Sell |
12,746
-927
| -7% | -$79K | 0.5% | 56 |
|
|
2019
Q4 | $1.21M | Buy |
13,673
+134
| +1% | +$11.1K | 0.45% | 70 |
|
|
2019
Q3 | $1.02M | Sell |
13,539
-1,356
| -9% | -$93K | 0.4% | 73 |
|
|
2019
Q2 | $1.08M | Buy |
14,895
+1,502
| +11% | +$118K | 0.42% | 68 |
|
|
2019
Q1 | $1.08M | Sell |
13,393
-1,398
| -9% | -$114K | 0.42% | 69 |
|
|
2018
Q4 | $1.36M | Sell |
14,791
-508
| -3% | -$44.7K | 0.61% | 50 |
|
|
2018
Q3 | $1.45M | Sell |
15,299
-640
| -4% | -$60.7K | 0.55% | 55 |
|
|
2018
Q2 | $1.48M | Buy |
15,939
+124
| +0.8% | +$12.1K | 0.6% | 53 |
|
|
2018
Q1 | $1.5M | Sell |
15,815
-780
| -5% | -$85.7K | 0.6% | 49 |
|
|
2017
Q4 | $1.6M | Sell |
16,595
-296
| -2% | -$27.9K | 0.59% | 52 |
|
|
2017
Q3 | $1.5M | Buy |
16,891
+35
| +0.2% | +$2.66K | 0.57% | 55 |
|
|
2017
Q2 | $1.22M | Buy |
16,856
+536
| +3% | +$36K | 0.56% | 53 |
|
|
2017
Q1 | $1.06M | Buy |
16,320
+3,234
| +25% | +$203K | 0.49% | 57 |
|
|
2016
Q4 | $819K | Buy |
13,086
+465
| +4% | +$28.4K | 0.38% | 66 |
|
|
2016
Q3 | $796K | Sell |
12,621
-3,970
| -24% | -$257K | 0.36% | 62 |
|
|
2016
Q2 | $1.03M | Buy |
16,591
+6
| +0% | +$366 | 0.51% | 55 |
|
|
2016
Q1 | $948K | Buy |
16,585
+1,274
| +8% | +$71K | 0.49% | 58 |
|
|
2015
Q4 | $907K | Sell |
15,311
-3,804
| -20% | -$219K | 0.48% | 59 |
|
|
2015
Q3 | $1.04M | Buy |
19,115
+220
| +1% | +$14.3K | 0.6% | 45 |
|
|
2015
Q2 | $1.27M | Buy |
18,895
+8,782
| +87% | +$573K | 0.82% | 23 |
|
|
2015
Q1 | $592K | Buy |
10,113
+377
| +4% | +$22.8K | 0.33% | 69 |
|
|
2014
Q4 | $637K | Sell |
9,736
-574
| -6% | -$36.2K | 0.34% | 62 |
|
|
2014
Q3 | $596K | Buy |
10,310
+423
| +4% | +$23.5K | 0.32% | 62 |
|
|
2014
Q2 | $558K | Buy |
9,887
+824
| +9% | +$43.2K | 0.3% | 62 |
|
|
2014
Q1 | $466K | Sell |
9,063
-5,525
| -38% | -$279K | 0.28% | 71 |
|
|
2013
Q4 | $770K | Buy |
14,588
+1,204
| +9% | +$59.2K | 0.42% | 49 |
|
|
2013
Q3 | $599K | Buy |
13,384
+559
| +4% | +$24.8K | 0.36% | 54 |
|
|
2013
Q2 | $530K | Buy |
+12,825
| New | +$561K | 0.29% | 64 |
|
Other funds holding ABBV
Cadence Bank NA's ABBV Position: Q3 2022 in Review
Cadence Bank NA reduced its AbbVie (ABBV) stake by 81% in Q3 2022, selling an estimated $1.88M and leaving 3,029 shares worth $406K. The position accounts for 2.52% of the portfolio, ranked #7.
Cadence Bank NA first reported a position in ABBV in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.56M in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Cadence Bank NA held 3,029 shares of AbbVie worth $406K as of Q3 2022.
- Cadence Bank NA sold 13,072 AbbVie shares in Q3 2022, an estimated $1.88M.
- AbbVie made up 2.52% of Cadence Bank NA's portfolio in Q3 2022, its #7 holding.
- Cadence Bank NA first reported a position in AbbVie in Q2 2013 and has held it in 38 quarters since.
- Cadence Bank NA's AbbVie position peaked at $2.56M in Q1 2022.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.